OncoQuest Pharmaceuticals Inc (078590) — Cash Flow Reinvestment Rate
OncoQuest Pharmaceuticals Inc (078590) has a Cash Flow Reinvestment Rate of 1.92x as of December 2025, reinvesting ₩1.01 Billion (capex ₩0.00 plus investments ₩1.01 Billion) from operating cash flow of ₩526.70 Million. Check OncoQuest Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
OncoQuest Pharmaceuticals Inc Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for OncoQuest Pharmaceuticals Inc across 9 annual periods. Explore OncoQuest Pharmaceuticals Inc (078590) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for OncoQuest Pharmaceuticals Inc (2014–2025)
Year-by-year capital reinvestment analysis for OncoQuest Pharmaceuticals Inc. For live market cap and broader valuation context, see OncoQuest Pharmaceuticals Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 14.78x | ₩7.17 Billion | ₩485.35 Million | ₩1.18 Billion | ▲ +429.7% |
| 2024 | 2.79x | ₩11.05 Billion | ₩3.96 Billion | ₩2.51 Billion | ▲ +541.0% |
| 2023 | 0.44x | ₩4.87 Billion | ₩11.19 Billion | ₩1.90 Billion | ▼ -89.2% |
| 2020 | 4.04x | ₩30.48 Billion | ₩7.55 Billion | ₩3.48 Billion | ▼ -15.0% |
| 2018 | 4.75x | ₩6.84 Billion | ₩1.44 Billion | ₩1.33 Billion | ▲ +254.0% |
| 2017 | 1.34x | ₩6.43 Billion | ₩4.79 Billion | ₩1.28 Billion | ▲ +187.2% |
| 2016 | 0.47x | ₩1.65 Billion | ₩3.54 Billion | ₩1.61 Billion | ▼ -55.8% |
| 2015 | 1.06x | ₩2.95 Billion | ₩2.79 Billion | ₩2.91 Billion | ▼ -13.8% |
| 2014 | 1.23x | ₩1.24 Billion | ₩1.02 Billion | ₩1.18 Billion | — |